Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ceftriaxone for Refractory Psychosis
NCT00591318Phase 2Terminated
- Sponsor
- Research Foundation for Mental Hygiene
- Start
- Oct 2007
- Primary completion
- Mar 2011
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing IV Ceftriaxone with IV Placebo (2 arms). Primary endpoint: Positive and Negative Syndrome Scale - Positive Subscale at 8 weeks. Started Oct 2007; status: terminated.
02
Drugs
ceftriaxone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00591318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591318.